
    
      The data collected in this study will be used to evaluate device outcomes and characterize
      trends in patient selection for MitraClip therapy in contemporary real-world use. Clinical
      outcomes and Echocardiographic measures will be assessed in the context of historical data.

      The MitraClip EXPAND Study will be conducted on commercial MitraClip NTR System and MitraClip
      XTR System that have received CE Mark and/or FDA approval as required.

      Up to 1,000 subjects at a maximum of 60 sites in Europe and the US will be in the MitraClip
      EXPAND Study.
    
  